Discover 1,548 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,548
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: 32 recruiting locations
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: 41 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
for
Colorectal Neoplasms, Breast Neoplasms, Head and Neck Neoplasms,
Location: 9 recruiting locations
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT07158164
Recruiting
Active & Responsive
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
for
End Stage Renal Disease (ESRD), Kidney Failure,
Location: 18 recruiting locations
Sponsor: W.L.Gore & Associates
Sex: All
Age: 18 - 70+
Code: NCT04671771
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 90 recruiting locations
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: 19 recruiting locations
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase1, Recruiting
Active & Responsive
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
for
Major Depressive Disorder
Location: 36 recruiting locations
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06564818
Phase3, Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: 21 recruiting locations
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
for
ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Location: 44 recruiting locations
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.